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Development of a Method for the Serological Differentiation Between Animals Either
Vaccinated with KilledVirus Vaccine or Infected by Bovine ViralDiarrhea Virus (BVDV)
Jimmy Kwang and E. Travis Llttledlke1

Introduction
Bovine viral diarrhea (BVO), caused by the BVO virus,
has been recognized in many parts of the world and is considered to have a marked economic impact on the cattle
industry. In the U.S. alone, serological surveys indicated
that 60 to 80% of the cattle population have antibodies to
the virus. There are many strains of bovine viral diarrhea
virus (BVOV) which differ in their ability to cause changes in
cell culture. Thus, cytopathic and noncytopathic biotypes of
BVOV are identified. The cytopathic strains induce a vacuolation of the infected cultured cells, where noncytopathic
strains do not.
Control of BVOV has been attempted for many years by
use of either modified-live or killed virus vaccines. The
killed virus vaccine is more commonly used. The modifiedlive virus vaccine is known to cause complications during
pregnancy, potentially fetopathogenic effects being a major
concern. There is evidence that vaccination of persistently
infected cattle with modified-live virus vaccine can result in
severe mucosal disease. Oue to the ubiquitous nature of
BVOV, producers may find advantages in designing BVO
control procedures for a herd to be able to differentiate
between cattle that 1) have received modified-live BVO
virus vaccination, 2) have received killed BVO virus vaccination, or 3) were naturally infected. This study explored the
potential of BVOV protein, p80, to allow differentiation of the
above three conditions.
The genome of an isolate of a BVOV strain has been
sequenced. Encoded within the genome are at least four
primary gene products (proteins): p20, gp116, p125, and
p133. There is evidence that p125 polypeptide precursor
gives rise to p80 polypeptide due to the breakdown of this
precursor protein in cells infected with BVOV. The p80 area
of the BVOV genome is well conserved in the many BVOV
strains that have been isolated.

Procedure
New molecular biology techniques permitted the manipulation of the BVOV genome to allow isolation and recombination of the p80 gene into a ONA structure designed for
production of the p80 specific protein. The recombinant p80
protein was produced, expressed, and purified in sufficient
quantities to develop a specific immuno-blot
assay for
BVOV antibodies in cattle sera. Twenty-four cattle sera
were tested: eight of the cattle were vaccinated with modified-live virus vaccine, eight were vaccinated with killed
virus vaccine, and eight were naturally infected with BVO.
Results
The immuno-blot assay that was developed was tested for
BVOV-p80 antigen-antibody reaction. When the BVOV-p80
protein was reacted with the cattle sera in the immuno-blot
test, the following results were obtained: all sera from modified-live virus vaccinated cattle were positive; all sera from
killed virus vaccinated cattle were negative, and all sera from
naturally infected cattle were positive (Table 1). Since p80 is
not a structural protein of the virus and the killed virus

doesn't replicate in the host cell, there is not sufficient paO
antigen in cattle vaccinated with killed BVO vaccine to cause
production of p80 antibodies in cattle. Therefore, cattle vaccinated with the killed BVO vaccine either do not make antibodies or do not produce detectable levels of antibodies to
the p80 region of the virus. Thus, the cattle test negative.
However, modified-live virus used for vaccination replicated
in the host cell after vaccination and produced large amounts
of p80; therefore, antibodies were produced in the cattle to
the paO and the cattle tested positive.
The significance of this finding is two-fold. First, p80 is
capable of differentiating
between the modified-live
and
killed virus vaccines. Second, if a herd was vaccinated only
with killed virus vaccine and tested with p80 immuno assay,
the expected results would be negative-if
the herd was
clean of BVOV. Any positive results would indicate that a
source of natural infection must be present in the herd. This
source could be from persistently viremic BVO carriers, that
mayor may not exhibit signs of the infection, but would
spread BVO throughout the herd and give birth to carrier
calves which would continue the spread of BVO in the herd.
To ultimately control BVOV, carriers of the BVO virus must
be identified and eliminated from the herd and no new carrier cattle added. In addition, effective vaccination of the
cattle before breeding would protect the fetal calves from
becoming carriers and perpetuating BVO in the herd.
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cattle vaccinated with either MLVV,KVV,or NI with
virus
Animalno.

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24

KVV

NI

-

178

MLW
KVV

Serum
neutralization test

MLVV

BVDV
'Kwang is a research microbiologist, Animal Health Systems Research
Unit, MARC, and Littledike is the research leader, Animal Health
Systems Research Unit, MARC.

BVDV
exposure

Bovine viral diarrhea

_ Modified.live
-

Killed virus vaccine.

NI _ Naturally

infected.

virus.

virus vaccine.

32
16
64
16
32
32
32
32
4
8
4
<2
<2
<2
4
8
>256
>256
>256
>256
128
>256
>256
128

paD
immune-blot assay

+
+
+
+
+
+
+
+

+
+
+
+
+
+
+
+

